Log In
BCIQ
Print this Print this
 

IONIS-AGT-LRx

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionLigand conjugated antisense oligonucleotides targeting angiotensinogen (AGT)
Molecular Target Angiotensinogen (AGT)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPreclinical
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today